Allogene Therapeutics (ALLO) Operating Expenses (2018 - 2026)
Allogene Therapeutics (ALLO) recorded Operating Expenses of $51.56 million in Q2 2026, down 9.3% from $56.82 million a year earlier but up 11.9% from the prior quarter.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Operating Expenses (2018 - 2026) Analysis & Trends
On a TTM basis, Allogene Therapeutics' Operating Expenses came in at $184.96 million as of Jun 30, 2026, down 27.3% year-over-year; for FY2025, it came in at $209.32 million, down 23.4% from FY2024.
- Annual Operating Expenses has declined for three straight years, with a five-year compound annual growth rate of -4.1% (FY2020 to FY2025).
- Across earlier years, Operating Expenses came in at $273.22 million in FY2024 (-16.7%), $327.83 million in FY2023 (-2.3%), $335.69 million in FY2022 (+14.1%) and $294.28 million in FY2021 (+14.0%).
- Quarterly Operating Expenses has ranged from $42.4 million in Q4 2025 to $99.12 million in Q1 2023 over the past five years.
- On a year-over-year basis, Operating Expenses has declined for seven consecutive quarters, with an average decline of 18.5% over the last eight quarters.
- Peak year-over-year performance for Operating Expenses in the last five years was growth of 30.4% in Q4 2022, against a decline of 37.4% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $46.09 million (Q1 2026), $42.4 million (Q4 2025) and $44.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.95 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 10.12 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.56 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 6.09 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 9.70 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 6.54 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 18.20 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 6.68 Bn |
| 10 | Allogene Therapeutics | 435.17 Mn | -666.72 Mn | - | 51.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.56 Mn |
| Mar 31, 2026 | 46.09 Mn |
| Dec 31, 2025 | 42.40 Mn |
| Sep 30, 2025 | 44.90 Mn |
| Jun 30, 2025 | 56.82 Mn |
| Mar 31, 2025 | 65.19 Mn |
| Dec 31, 2024 | 60.49 Mn |
| Sep 30, 2024 | 71.77 Mn |
| Jun 30, 2024 | 71.43 Mn |
| Mar 31, 2024 | 69.53 Mn |
| Dec 31, 2023 | 85.13 Mn |
| Sep 30, 2023 | 63.02 Mn |
| Jun 30, 2023 | 80.56 Mn |
| Mar 31, 2023 | 99.12 Mn |
| Dec 31, 2022 | 96.42 Mn |
| Sep 30, 2022 | 82.54 Mn |
| Jun 30, 2022 | 76.68 Mn |
| Mar 31, 2022 | 80.05 Mn |
| Dec 31, 2021 | 73.94 Mn |
| Sep 30, 2021 | 77.72 Mn |
API Access
Allogene Therapeutics Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();